Brent K. Hollenbeck

15.7k total citations · 3 hit papers
368 papers, 10.6k citations indexed

About

Brent K. Hollenbeck is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Economics and Econometrics. According to data from OpenAlex, Brent K. Hollenbeck has authored 368 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 181 papers in Pulmonary and Respiratory Medicine, 117 papers in Surgery and 100 papers in Economics and Econometrics. Recurrent topics in Brent K. Hollenbeck's work include Prostate Cancer Diagnosis and Treatment (97 papers), Bladder and Urothelial Cancer Treatments (72 papers) and Prostate Cancer Treatment and Research (70 papers). Brent K. Hollenbeck is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (97 papers), Bladder and Urothelial Cancer Treatments (72 papers) and Prostate Cancer Treatment and Research (70 papers). Brent K. Hollenbeck collaborates with scholars based in United States, Nepal and United Kingdom. Brent K. Hollenbeck's co-authors include David C. Miller, John M. Hollingsworth, John T. Wei, Rodney L. Dunn, Stephanie Daignault, J. Stuart Wolf, James E. Montie, Ted A. Skolarus, David A. Taub and Gary J. Faerber and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Brent K. Hollenbeck

351 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rising Incidence of Small Renal Masses: A Need to Reassess Treatment Effect

2006 859 citations John M. Hollingsworth, David C. Miller et al. profile →
Best Practice Policy Statement on Urologic Surgery Antimicrobial Prophylaxis

2008 576 citations Brent K. Hollenbeck et al. The Journal of Urology profile →
The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease

2014 393 citations Brent K. Hollenbeck, Simon P. Kim et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brent K. Hollenbeck United States	53	5.7k	4.2k	1.9k	1.7k	1.6k	368	10.6k
Angel M. Cronin United States	55	4.1k 0.7×	3.0k 0.7×	2.4k 1.3×	1.0k 0.6×	982 0.6×	206	11.7k
Quoc‐Dien Trinh United States	63	8.1k 1.4×	5.2k 1.2×	3.6k 1.9×	1.6k 1.0×	2.1k 1.3×	558	14.7k
Christopher S. Saigal United States	45	5.6k 1.0×	2.7k 0.7×	1.3k 0.7×	2.2k 1.3×	752 0.5×	209	10.2k
John L. Gore United States	44	3.3k 0.6×	3.1k 0.7×	1.8k 1.0×	1.3k 0.8×	1.3k 0.8×	315	7.9k
Maxine Sun United States	64	9.8k 1.7×	6.4k 1.5×	3.3k 1.7×	1.9k 1.1×	3.1k 1.9×	435	15.8k
Jim C. Hu United States	57	7.2k 1.3×	2.9k 0.7×	2.7k 1.4×	1.3k 0.8×	623 0.4×	357	11.7k
Adam S. Kibel United States	60	8.7k 1.5×	4.6k 1.1×	3.4k 1.8×	1.7k 1.0×	3.3k 2.0×	605	15.9k
David C. Miller United States	41	4.7k 0.8×	2.4k 0.6×	1.3k 0.7×	707 0.4×	2.2k 1.3×	181	6.8k
Christopher J. Kane United States	60	9.4k 1.7×	2.6k 0.6×	2.9k 1.5×	1.3k 0.8×	2.3k 1.4×	423	13.2k
Matthew E. Nielsen United States	52	2.9k 0.5×	4.3k 1.0×	1.7k 0.9×	1.6k 0.9×	1.6k 1.0×	235	8.2k

Countries citing papers authored by Brent K. Hollenbeck

Since Specialization

Citations

This map shows the geographic impact of Brent K. Hollenbeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brent K. Hollenbeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brent K. Hollenbeck more than expected).

Fields of papers citing papers by Brent K. Hollenbeck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brent K. Hollenbeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brent K. Hollenbeck. The network helps show where Brent K. Hollenbeck may publish in the future.

Co-authorship network of co-authors of Brent K. Hollenbeck

This figure shows the co-authorship network connecting the top 25 collaborators of Brent K. Hollenbeck. A scholar is included among the top collaborators of Brent K. Hollenbeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brent K. Hollenbeck. Brent K. Hollenbeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oerline, Mary, Samuel R. Kaufman, Arnav Srivastava, et al.. (2024). The 340B Program and High-Risk Prescribing of Oral Targeted Therapies for Advanced Prostate Cancer. Urology Practice. 11(6). 931–938.

Ying, Meiling, et al.. (2024). Factors affecting Accountable Care Organizations’ decisions to remain in or exit the Medicare Shared Savings Program following Pathways to Success. Health Affairs Scholar. 2(1). qxad093–qxad093. 1 indexed citations

Caram, Megan E.V., et al.. (2024). Addressing financial toxicity in cancer treatment—An opportunity for the 340B drug pricing program. Cancer. 130(18). 3077–3081. 2 indexed citations

Srivastava, Arnav, Xiu Liu, Avinash Maganty, et al.. (2024). Commercial prices and their influence on urology practices: Prostate cancer care among men with Medicare. Cancer. 131(1). e35633–e35633.

Kaufman, Samuel R., Lindsey A. Herrel, Avinash Maganty, et al.. (2023). The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer Medicine. 12(24). 22325–22332. 1 indexed citations

Maganty, Avinash, Samuel R. Kaufman, Mary Oerline, et al.. (2023). Value‐based payment models and management of newly diagnosed prostate cancer. Cancer Medicine. 13(1). e6810–e6810. 2 indexed citations

Kaufman, Samuel R., Mary Oerline, Megan E.V. Caram, et al.. (2023). In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer. JNCI Cancer Spectrum. 7(5).

Kaufman, Samuel R., Lindsey A. Herrel, Avinash Maganty, et al.. (2023). Acquisition of Urology Practices by Private Equity Firms and Performance in the Merit-based Incentive Payment System. Urology Practice. 10(6). 597–603.

Mmonu, Nnenaya A., Yongmei Qin, Samuel R. Kaufman, et al.. (2023). Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities. JCO Oncology Practice. 19(5). e763–e772. 2 indexed citations

10.

Chapman, Christina, Megan E.V. Caram, Archana Radhakrishnan, et al.. (2019). Association between PSA values and surveillance quality after prostate cancer surgery. Cancer Medicine. 8(18). 7903–7912. 5 indexed citations

11.

Filson, Christopher P., John M. Hollingsworth, Chang He, et al.. (2016). Patient-Reported Convalescence and Quality of Life Recovery. Surgical Innovation. 23(6). 598–605. 10 indexed citations

12.

Hollenbeck, Brent K., Samuel R. Kaufman, Lindsey A. Herrel, et al.. (2016). Implications of evolving delivery system reforms for prostate cancer care.. PubMed. 22(9). 569–75. 28 indexed citations

13.

Suskind, Anne M., J. Quentin Clemens, Yun Zhang, & Brent K. Hollenbeck. (2015). Physician Use of Sacral Neuromodulation Among Medicare Beneficiaries With Overactive Bladder and Urinary Retention. Urology. 86(1). 30–34. 10 indexed citations

14.

Skolarus, Ted A., Timothy P. Hofer, Jeffrey S. Montgomery, et al.. (2015). Urologist Workforce Variation Across the VHA.. Europe PMC (PubMed Central). 32(3). 18–22. 2 indexed citations

15.

Schroeck, Florian R., Samuel R. Kaufman, Bruce L. Jacobs, et al.. (2014). Technology Diffusion and Prostate Cancer Quality of Care. Urology. 84(5). 1066–1072. 3 indexed citations

16.

Ellison, Jonathan S., Samuel R. Kaufman, Kate H. Kraft, et al.. (2014). Underuse of 24-Hour Urine Collection Among Children With Incident Urinary Stones: A Quality-of-care Concern?. Urology. 84(2). 457–461. 17 indexed citations

17.

Suskind, Anne M., J. Quentin Clemens, Rodney L. Dunn, et al.. (2013). Effectiveness of Mesh Compared With Nonmesh Sling Surgery in Medicare Beneficiaries. Obstetrics and Gynecology. 122(3). 546–552. 8 indexed citations

18.

Hollenbeck, Brent K., Rodney L. Dunn, Zaojun Ye, et al.. (2010). Delays in diagnosis and bladder cancer mortality. Cancer. 116(22). 5235–5242. 123 indexed citations

19.

Hollingsworth, John M., Rodney L. Dunn, Zaojun Ye, & Brent K. Hollenbeck. (2009). RACIAL DIFFERENCES IN TREATMENT AND OUTCOMES AMONG PATIENTS WITH EARLY STAGE BLADDER CANCER. The Journal of Urology. 181(4). 690–690. 1 indexed citations

20.

Hollenbeck, Brent K., Yongliang Wei, & John D. Birkmeyer. (2007). Volume, Process of Care, and Operative Mortality for Cystectomy for Bladder Cancer. Urology. 69(5). 871–875. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact